vitro susceptibility pseudomonas four betalactamantibiotics ampicillin cephalothin carbenicillin piperacillin four aminoglycosides kanamycin amikacin gentamicin tobramycin colimycin 97 welldefined strain pseudomonas isolated sputum patient cystic fibrosis cf minimum inhibitory concentration mic several antibiotic determined broth dilution method majority strain resistant ampicillin cephalothin moderately susceptible carbenicillin 70 100 microgramml highly susceptible piperacillin 100 25 microgramml 88 625 microgram 60 312 microgramml pharmacological property piperacillin comparable carbenicillin expected sputum level drug adequate treat pseudomonas pulmonary infection lowest concentration tested 078 microgramml 3 strain susceptible kanamycin 855 amikacin 95 gentamicin 98 tobramycin 80 colimycin regard clinically attainable concentration 989 strain susceptible gentamicin tobramycin 979 amikacin 969 colimycin 886 piperacillin 38 carbenicillin 257 kanamycin 123 ampicillin 1 cephalothin